Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001033408-07-000001
Filing Date
2007-01-04
Accepted
2007-01-04 15:26:53
Documents
1
Period of Report
2007-01-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 20347
  Complete submission text file 0001033408-07-000001.txt   22180
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Issuer) CIK: 0001003124 (see all company filings)

EIN.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412
Business Address 9102510081
MCNEILL JOHN A JR (Reporting) CIK: 0001033408 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27570 | Film No.: 07509007